|Grant Affiliation:||Shattock: Novel Antigens for Mucosal Protection|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2006-11-02|
|Study Made Public:||2011-02-25|
Neutralization activity of sera collected from rabbits immunized with a recombinant clade C HIV gp140 by the intravaginal route.
CAVD 286 is an immunogenicity study of samples from a preclinical rabbit study of a recombinant Clade C protein.
Sign in to see full information about this study and to download study data.
No integrated data is available for this study.
No non-integrated data is available for this study.